ES2847867T3 - Métodos y composiciones para preparar muestras para inmunotinción - Google Patents

Métodos y composiciones para preparar muestras para inmunotinción Download PDF

Info

Publication number
ES2847867T3
ES2847867T3 ES12791608T ES12791608T ES2847867T3 ES 2847867 T3 ES2847867 T3 ES 2847867T3 ES 12791608 T ES12791608 T ES 12791608T ES 12791608 T ES12791608 T ES 12791608T ES 2847867 T3 ES2847867 T3 ES 2847867T3
Authority
ES
Spain
Prior art keywords
sample
solution
antibody
antigen
kit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES12791608T
Other languages
English (en)
Spanish (es)
Inventor
Timothy Fischer
Ramona Nelson
Adriann Taylor
Clark Whitehead
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TriPath Imaging Inc
Original Assignee
TriPath Imaging Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TriPath Imaging Inc filed Critical TriPath Imaging Inc
Application granted granted Critical
Publication of ES2847867T3 publication Critical patent/ES2847867T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/5759—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds localised on the membrane of tumour or cancer cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Oncology (AREA)
ES12791608T 2011-11-03 2012-11-02 Métodos y composiciones para preparar muestras para inmunotinción Active ES2847867T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161555139P 2011-11-03 2011-11-03
PCT/US2012/063183 WO2013067268A1 (en) 2011-11-03 2012-11-02 Methods and compositions for preparing samples for immunostaining

Publications (1)

Publication Number Publication Date
ES2847867T3 true ES2847867T3 (es) 2021-08-04

Family

ID=47228039

Family Applications (1)

Application Number Title Priority Date Filing Date
ES12791608T Active ES2847867T3 (es) 2011-11-03 2012-11-02 Métodos y composiciones para preparar muestras para inmunotinción

Country Status (5)

Country Link
US (1) US10527526B2 (https=)
EP (1) EP2773390B1 (https=)
JP (1) JP6301258B2 (https=)
ES (1) ES2847867T3 (https=)
WO (1) WO2013067268A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2518468B1 (en) * 2011-04-26 2019-07-24 Milestone S.r.l. Method, processor and carrier for processing frozen slices of tissue of biospecimens
US20140170727A1 (en) * 2012-12-19 2014-06-19 Nanomr, Inc. Affinity medium using fixed whole cells
JP6311707B2 (ja) 2013-05-13 2018-04-18 コニカミノルタ株式会社 細胞染色方法及びその方法に使用する検体採取管
WO2019078655A1 (ko) * 2017-10-19 2019-04-25 재단법인대구경북과학기술원 설포베타인계 쯔비터이온성 계면활성제를 포함하는 생물학적 분자의 조직침투용 조성물 및 이의 용도

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3479158D1 (en) * 1983-03-04 1989-08-31 Noctech Ltd Diagnostic agent, a process for its preparation and its use in diagnostic methods
US4658022A (en) * 1985-08-08 1987-04-14 Molecular Diagnostics, Inc. Binding of antibody reagents to denatured protein analytes
US5173422A (en) * 1986-08-22 1992-12-22 Miles Inc. Monoclonal antibodies specific for human glycoalbumin
EP0436597B1 (en) 1988-09-02 1997-04-02 Protein Engineering Corporation Generation and selection of recombinant varied binding proteins
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
EP0585287B1 (en) 1990-07-10 1999-10-13 Cambridge Antibody Technology Limited Methods for producing members of specific binding pairs
CA2405246A1 (en) 1990-12-03 1992-06-11 Genentech, Inc. Enrichment method for variant proteins with alterred binding properties
EP0575485A1 (en) 1991-03-01 1993-12-29 Dyax Corp. Process for the development of binding mini-proteins
DK0580737T3 (da) 1991-04-10 2004-11-01 Scripps Research Inst Heterodimere receptorbiblioteker ved anvendelse af phagemider
US5316814A (en) 1991-05-14 1994-05-31 Ricoh Company, Ltd. Optical information recording medium
DE4122599C2 (de) 1991-07-08 1993-11-11 Deutsches Krebsforsch Phagemid zum Screenen von Antikörpern
US5346831A (en) 1992-09-29 1994-09-13 Hoffman-La Roche Inc. Cytorich process system
US5658636A (en) 1995-01-27 1997-08-19 Carnegie Mellon University Method to prevent adhesion of micromechanical structures
US5945515A (en) 1995-07-31 1999-08-31 Chomczynski; Piotr Product and process for isolating DNA, RNA and proteins
US5861295A (en) 1997-01-02 1999-01-19 Life Technologies, Inc. Nucleic acid-free thermostable enzymes and methods of production thereof
AU740441B2 (en) * 1998-06-30 2001-11-01 La Mina Ltd Cytological and histological fixative composition and methods of use
US7306926B2 (en) 1998-07-01 2007-12-11 Mtm Laboratories Ag Method for detecting carcinomas in a solubilized cervical body sample
DE19829473C2 (de) 1998-07-01 2000-08-10 Magnus Von Knebel Doeberitz Ch Verfahren zur frühen Diagnose von Carcinomen
US7550298B2 (en) 1998-09-03 2009-06-23 Ventana Medical Systems, Inc. Automated immunohistochemical and in situ hybridization assay formulations
US20020076732A1 (en) * 2000-12-15 2002-06-20 Kaplan David R. Methods for detecting an analyte of interest using catalyzed reporter deposition of tyramide
US7357928B2 (en) * 2002-04-08 2008-04-15 University Of Louisville Research Foundation, Inc. Method for the diagnosis and prognosis of malignant diseases
DE10231659B4 (de) * 2002-07-12 2006-01-19 Preanalytix Gmbh Zusammensetzung zum Binden von Nukleinsäure an eine Festphase
DE60200248T2 (de) 2002-08-01 2005-01-27 Mtm Laboratories Ag Verfahren für Lösung-basierte Diagnose
WO2004108741A1 (en) 2003-06-04 2004-12-16 Qiagen As Process for the concentration and/or isolation of nucleic acid or nucleic acid-containing species
US20040265800A1 (en) 2003-06-30 2004-12-30 Sysmex Corporation Sample pretreatment solution for immunological test and method for using the same
ATE549625T1 (de) 2004-03-24 2012-03-15 Tripath Imaging Inc Verfahren und zusammensetzungen zum nachweis einer zervixerkrankung
EP1805676A1 (en) * 2004-09-22 2007-07-11 Tripath Imaging, Inc. Methods and computer program products for analysis and optimization of marker candidates for cancer prognosis
US7595380B2 (en) 2005-04-27 2009-09-29 Tripath Imaging, Inc. Monoclonal antibodies and methods for their use in the detection of cervical disease
EP1920072A2 (en) * 2005-07-01 2008-05-14 Dako Denmark A/S In situ hybridization detection method
EP1816460B1 (en) * 2006-02-03 2009-07-22 MTM Laboratories AG Method of performing a denaturing immunassay
US20070218512A1 (en) * 2006-02-28 2007-09-20 Alex Strongin Methods related to mmp26 status as a diagnostic and prognostic tool in cancer management
US7964356B2 (en) * 2007-01-16 2011-06-21 Somalogic, Inc. Method for generating aptamers with improved off-rates
JP2008212009A (ja) 2007-02-28 2008-09-18 Sysmex Corp Ｄｎａメチル化検出用試料の調製方法
US20080306610A1 (en) * 2007-06-07 2008-12-11 Zimmer Orthobiologics, Inc. Tissue processing for nonimmunogenic implants
EP2133069A1 (en) * 2008-06-12 2009-12-16 Lifebond Process for manufacture of gelatin solutions and products thereof
JP5826752B2 (ja) * 2009-09-14 2015-12-02 キアジェン ゲイサーズバーグ インコーポレイテッド 細胞学用培地に固定された組織サンプルから核酸またはタンパク質を回収するための組成物および方法
JP5452217B2 (ja) * 2009-12-28 2014-03-26 シスメックス株式会社 試料中のｃ型肝炎ウイルスの有無を判定する方法、及びｃ型肝炎ウイルスの有無を判定するための試薬キット
CN102081018A (zh) * 2009-11-30 2011-06-01 希森美康株式会社 样品的预处理方法及hcv的免疫测定方法
ES2719816T3 (es) * 2010-02-26 2019-07-16 Decell Tech Inc Métodos para la descelularización de tejidos
GB201005601D0 (en) 2010-04-01 2010-05-19 Nanoco Technologies Ltd Ecapsulated nanoparticles

Also Published As

Publication number Publication date
JP2014534446A (ja) 2014-12-18
EP2773390A1 (en) 2014-09-10
JP6301258B2 (ja) 2018-03-28
US10527526B2 (en) 2020-01-07
EP2773390B1 (en) 2020-12-30
US20130164760A1 (en) 2013-06-27
WO2013067268A1 (en) 2013-05-10

Similar Documents

Publication Publication Date Title
Hussaini et al. Immunohistochemistry and immunofluorescence
Mebratie et al. Review of immunohistochemistry techniques: Applications, current status, and future perspectives
Stumptner et al. The impact of crosslinking and non-crosslinking fixatives on antigen retrieval and immunohistochemistry
Nasr et al. Immunofluorescence on pronase-digested paraffin sections: a valuable salvage technique for renal biopsies
Hinterberger et al. D2-40 and calretinin—a tissue microarray analysis of 341 malignant mesotheliomas with emphasis on sarcomatoid differentiation
Simon et al. Immunohistochemical analysis of tissue microarrays
Mase et al. HBME-1 immunostaining in thyroid tumors especially in follicular neoplasm
Liu et al. Significance of CK19, TPO, and HBME-1 expression for diagnosis of papillary thyroid carcinoma
WO2000023799A1 (en) Protein quantitation with cell imaging densitometry
ES2847867T3 (es) Métodos y composiciones para preparar muestras para inmunotinción
Moreno et al. Fluorescent immunohistochemistry
US20200400674A1 (en) A method of detecting magea4
Denda et al. Optimal antigen retrieval for ethanol‐fixed cytologic smears
Steele et al. Multiplex immunohistochemistry for image analysis of tertiary lymphoid structures in cancer
Srebotnik Kirbiš et al. Optimization and validation of immunocytochemical detection of oestrogen receptors on cytospins prepared from fine needle aspiration (FNA) samples of breast cancer
Pirog Diagnosis of HPV-negative, gastric-type adenocarcinoma of the endocervix
WO2010066252A1 (en) Method for evaluating pre-treatment
Nicolazzo et al. Molecular characterization of circulating tumor cells to study cancer immunoevasion
Goel et al. Immunohistochemical characterization of normal ovary and common epithelial ovarian neoplasm with a monoclonal antibody to cytokeratin and vimentin
Chen et al. Non-invasive urinary sediment double-immunostaining predicts BK polyomavirus associated-nephropathy in kidney transplant recipients
EP2357197A1 (en) Anti-HPV E7 antibodies
Mukhtar et al. Correlation between HER2/neu protein overexpression on Immunohistochemistry and Fluorescent in Situ Hybridization (FISH) in breast carcinoma: Problems in developing countries
Santangelo et al. Special staining techniques: application and quality assurance
Yalcin et al. Diagnostic utility of immunocytochemistry by using liquid-based cytology (LBC) slides
Fu et al. A novel diagnostic marker, p28GANK distinguishes hepatocellular carcinoma from potential mimics